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Abstract
Introduction:  Non-cardiac  chest  pain  (NCCP)  is  mainly  related  to  oesophageal  disease,  and  in
spite of  being  a  common  condition  in  Mexico,  information  regarding  it  is  scarce.
Aim: To  assess  the  clinical  characteristics  and  health-related  quality  of  life  of  patients  with
NCCP of  presumed  oesophageal  origin.
Material  and  methods:  Patients  with  NCCP  of  presumed  oesophageal  origin  with  no  previ-
ous treatment  were  included  in  the  study.  Associated  symptoms  were  assessed  and  upper
gastrointestinal  endoscopy  and  24-hour  oesophageal  pH  monitoring  were  performed  to  diag-
nose gastroesophageal  reﬂux  disease,  while  oesophageal  manometry  was  used  to  determine
oesophageal  motility  disorders.  The  SF-36  Health-Related  Quality  of  Life  (HR-QoL)  questionnaire
was completed  and  its  results  compared  to  a  control  group  without  oesophageal  symptoms.
Results:  The  study  included  33  patients,  of  which  61%  were  women,  and  the  mean  age  was
46.1 (±  11.6)  years.  Causes  of  NCCP  were  gastroesophageal  reﬂux  disease  in  48%,  achalasia
in 34%,  and  functional  chest  pain  in  18%.  The  average  progression  time  for  chest  pain  was  24
(2-240) months,  with  ≤3  events/week  in  52%  of  the  patients.  The  most  frequent  accompanying
symptoms  were:  regurgitation  (81%),  dysphagia  (72%)  and  heartburn  (66%).  Patients  with  NCCP
show deterioration  in  HR-QoL  compared  to  the  control  group  (P  =  .01),  regardless  of  chest  pain
aetiology.  The  most  affected  areas  were  general  perception  of  health,  emotional  issues,  and
mental health  sub-scale  (P  >  0.05).
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Conclusions:  In  our  population,  patients  with  NCCP  show  deterioration  in  HR-QoL  regardless  of
the aetiology,  frequency,  and  accompanying  symptoms.
Published  by  Masson  Doyma  México  S.A.  on  behalf  of  Asociación  Mexicana  de  Gastroenterología.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Evaluación  clínica  y  de  la  calidad  de  vida  relacionada  con  la  salud  en  pacientes  con
dolor  torácico  no  cardiaco
Resumen
Introducción:  El  dolor  torácico  no  cardiaco  (DTNC)  se  relaciona  principalmente  con  enfer-
medades del  esófago,  y  aunque  se  considera  una  condición  común,  en  México  la  información
aún es  escasa.
Objetivo:  Evaluar  las  características  clínicas  y  la  calidad  de  vida  relacionada  con  salud  en
pacientes  con  DTNC  de  presunto  origen  esofágico.
Material  y  métodos:  Se  incluyeron  en  el  estudio  pacientes  con  DTNC  de  presunto  origen
esofágico,  sin  tratamiento  previo.  Se  evaluaron  los  síntomas  asociados,  se  realizó  endoscopia
alta y  monitorización  de  pH  esofágico  de  24  h  para  establecer  el  diagnóstico  de  enfermedad  por
reﬂujo gastroesofágico,  y  para  descartar  trastornos  en  la  motilidad  esofágica  se  llevó  a  cabo
manometría  esofágica.  Se  aplicó  el  cuestionario  de  calidad  de  vida  SF-36,  y  los  resultados  se
compararon  con  un  grupo  control  de  sanos.
Resultados:  Se  incluyeron  33  pacientes,  el  61%  mujeres,  y  la  edad  promedio  fue  46.1  (±  11.6)
an˜os. Las  causas  de  DTNC  fueron:  enfermedad  por  reﬂujo  gastroesofágico  48%,  acalasia  34%
y dolor  torácico  funcional  18%.  El  tiempo  promedio  de  progresión  del  dolor  torácico  fue  24
(2-240) meses,  con  ≤  3  eventos/semana  en  el  52%.  Los  síntomas  acompan˜antes  más  frecuentes
fueron:  regurgitaciones  (81%),  disfagia  (72%)  y  pirosis  (66%).  Los  pacientes  con  DTNC  muestran
deterioro  en  su  calidad  de  vida  comparado  con  el  grupo  control,  independientemente  de  la
etiología del  dolor  torácico.  Los  dominios  más  afectados  son  la  percepción  general  de  salud,
problemas  emocionales  y  la  subescala  de  salud  mental,  sin  diferencia  estadística  signiﬁcativa
(P >  0.05).
Conclusiones:  En  nuestra  población,  los  pacientes  con  DTNC  muestran  deterioro  en  su  calidad
de vida  independientemente  de  la  etiología,  frecuencia  y  síntomas  que  acompan˜an  al  dolor
torácico.
Publicado por  Masson  Doyma  México  S.A.  en  nombre  de  Asociación  Mexicana  de  Gas-
troenterología.  Este  es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Mntroduction
on-cardiac  chest  pain  (NCCP)  is  deﬁned  as  episodes
f  non-burning,  recurrent  retrosternal  pain  that  is  unre-
ated  to  cardiac  disease,  and  frequently  originates  in  the
astrointestinal  tract.  It  is  a  common  disorder  affecting
pproximately  one  third  of  the  general  population  at  some
oint  in  their  lives,  is  equally  prevalent  in  both  sexes,  and
an  appear  from  childhood  to  adulthood.1,2
NCCP  has  several  known  causes  of  presumed  esophageal
rigin;  of  these,  gastroesophageal  reﬂux  disease  (GERD)
s  the  most  frequent,  producing  more  than  60%  of  the
ases.  Others  are  motor  disorders  of  the  esophagus  and  vis-
eral  hypersensitivity,  which  include  psychiatric  disorders.
ccording  to  the  Rome  III  criteria,  chest  pain  (CP)  is  consid-
red  functional  (functional  CP  [FCP])  once  GERD  and  motor
isorders  have  been  ruled  out  as  its  causes.3--9Although  the  natural  history  of  the  disease  is  still  not
ell  known,  it  has  been  reported  that  patients  with  NCCP
ave  a  good  prognosis,  with  10-year  mortality  rates  below
A
o%.  However,  morbidity  is  high  as  a  result  of  daily  activity
imitations  and  absenteeism  in  the  workplace,  which  have  a
egative  impact  on  quality  of  life.8,10--13 It  has  been  calcu-
ated  that  in  the  United  States,  a  large  number  of  resources
n  the  health  sector  are  used  for  the  study  and  treatment  of
CCP.14
Studies  that  have  analyzed  NCCP  and  quality  of  life  in  the
ast  report  that,  in  general,  quality  of  life  is  poor  and  the
cales  with  the  greatest  impact  are  related  to  physical  func-
ion  (physical  performance),  the  perception  of  health,  and
ental  health.14 Nevertheless,  the  relation  between  etiol-
gy  and  quality  of  life  deterioration  has  yet  to  be  studied.
The  aim  of  the  present  study  was  to  evaluate  clinical
haracteristics  and  quality  of  life  regarding  the  health  of
atients  with  NCCP  of  presumed  esophageal  origin.
ethodsll  patients  diagnosed  with  NCCP  of  presumed  esophageal
rigin  arriving  at  the  Gastroenterology  and  Endoscopy
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fClinical  assessment  and  health-related  quality  of  life  in  pati
Services  of  the  ‘‘Hospital  de  Especialidades,  Centro  Médico
Nacional  Siglo  XXI’’  between  June  2007  and  June  2009
were  invited  to  participate  in  the  study.  Four  groups
were  included:  1)  patients  with  NCCP  associated  with
GERD:  a)  as  diagnosed  by  abnormal  24-h  esophageal  pH-
monitoring  (total  time  with  pH  <  4  in  24  h  >  4.2%  and/or
Johnson-DeMeester  index  >14.72),15 plus  endoscopy  data
indicating  GERD  (erosion  of  the  distal  esophagus  or  chronic
complications  such  as  Barrett’s  metaplasia),  and  b)  patients
with  an  abnormal  24-h  esophageal  pH-monitoring  in  the
absence  of  endoscopically  visible  esophageal  mucosal
injuries  (nonerosive  reﬂux  disease  [NERD]  patients);  2)
patients  with  FCP  as  deﬁned  by  the  Rome  III  criteria  when
endoscopy  of  the  upper  gastrointestinal  tract,  esophageal
manometry,  and  ambulatory  24-h  pH  monitoring  were
normal;9 3)  patients  diagnosed  with  classic  achalasia
without  previous  treatment  (classic  achalasia  is  deﬁned  by
incomplete  lower  esophageal  sphincter  [LES]  relaxation  and
aperistalsis  of  the  esophagus);16,17 and  4)  a  control  group
including  51  healthy  subjects  with  a  mean  age  of  35  (±  13.5)
years;  31  women  and  20  men.  All  controls  had  a  complete
medical  history  and  none  of  the  volunteers  had  a  history  of
esophageal  symptoms,  surgery  of  the  digestive  tract,  or  the
ingestion  of  any  medication  that  could  affect  gastrointesti-
nal  function.  They  were  recruited  in  the  same  time  period
and  completed  the  SF-36  questionnaire  on  quality  of  life.
All  patients  underwent  a  complete  medical  history  and
answered  the  SF-36  quality  of  life  questionnaire.
NCCP  was  deﬁned  by  the  presence  of  at  least  two
episodes  of  non-burning  retrosternal  CP  per  week,  within  the
last  3  months,9 once  acute  coronary  disease  had  been  ruled
out  as  the  cause  of  CP  by  electrocardiogram,  the  Bruce  pro-
tocol  stress  test,  thallium  stress  test,  and  coronarography
referred  by  a  cardiologist.
Exclusion  criteria  were  as  follows:  treatment  with  proton
pump  inhibitors  (PPIs)  or  H2 receptor  antagonists,  calcium
channel  blockers,  beta-blockers  and/or  nitrates  seven  days
before  the  study;  a  history  of  previous  esophageal  surgery;
a  history  of  serious  neurologic  or  psychiatric  disease  under
current  treatment;  vigorous  achalasia,  and  refusal  to  par-
ticipate  in  the  study.  All  patients  that  agreed  to  participate
in  the  study  gave  their  written  consent.  The  study  was
approved  by  the  Ethics  Committee  of  the  Hospital  de  Espe-
cialidades  del  Centro  Médico  Nacional  Siglo  XXI,  IMSS, in
Mexico  City  and  was  carried  out  according  to  the  health
research  norms  of  the  Department  of  Health.
Study  Protocol
All  patients  were  assessed  by  a  gastroenterologist  who
questioned  them  and  determined  the  frequency  and  time
of  progression  for  each  of  the  symptoms  (CP,  dysphagia,
heartburn,  regurgitation,  odynophagia,  nocturnal  cough,
dysphonia,  and  weight  loss).  The  following  scale  was
employed:
Frequency:  0)  Absent;  1)  Present  ≤  once  a  month;  2)
Present  ≤  once  a  week;  3)  Present  ≤  3  times  a  week;  4)
Present  ≥  3  times  a  week  or  every  day;  and  5)  Present  at
every  meal.
Weight  loss  was  calculated  in  kilograms  and  was  deter-
mined  from  the  period  of  symptom  onset  to  the  time
N
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f  diagnosis.  Time  of  disease  progression  was  reported  in
onths  for  each  of  the  symptoms  present.
Patients  were  protocolized  as  shown  in  ﬁgure  1:
pper  Gastrointestinal  Endoscopy
pper  gastrointestinal  endoscopy  was  performed  and  inter-
reted  by  the  same  group  of  gastroenterology  endoscopists.
ujinon®  EG  201FP  video-endoscopic  equipment  was  used.
ach  patient  had  been  fasting  for  six  hours  and  was  placed
n  the  left  lateral  decubitus  position,  while  the  endoscopic
xamination  was  performed  with  the  standard  technique.18
he  distal  esophagus  was  carefully  examined  to  detect
he  presence  of  lesions  in  the  esophageal  mucosa  and
ts  continuity  was  graded  according  to  the  Los  Angeles
lassiﬁcation.19
tationary  esophageal  manometry
ach  patient  arrived  at  the  Motility  Laboratory  having  fasted
or  6  h;  the  study  was  performed  with  the  stationary  pull-
hrough  technique.20 In  all  cases,  a  water  perfusion  system
as  placed  through  the  nose.  It  consisted  of  a  catheter
ade  of  4 radially  oriented  channels  with  diameters  of
.5  mm  that  were  situated  at  a  distance  of  50  mm  from  each
ther  (Alpine  BioMed  Manometric  Catheter,  Alpine  Biomed,
orp,  17800  Newhope  St,  Suite  B,  Fountaine  Valley,  CA,
2708  USA  and  Zinetics  Manometric  Catheter,  Medtronic
/S,  Tonsbakken  16-18,  DK-2740  Skovunde,  Denmark).  The
atheter  was  continuously  perfused  at  0.5  mL/min  by  a
ydro-pneumatic  infusion  pump  connected  to  the  Solar
PS-2020  polygraph  measurement  system  (PO  Box  580,
500  AN  Enschede,  The  Netherlands).  Changes  in  intrae-
ophageal  pressure  were  converted  into  an  electric  signal
y  a  transducer  and  then  recorded  on  the  computer  (sta-
ionary  motility  systems,  software  version  8,  GI  Manometry,
MS  b.v.).  The  manometric  tracings  were  interpreted  by
 specialist  and  motor  disorders  were  evaluated  accord-
ng  to  the  2001  Classiﬁcation  Criteria  of  Esophageal  Motility
isorders.16,21
4-h  ambulatory  pH  monitoring
ortable  equipment  (Digitrapper  pH  400  Medtronic  2003,
enmark)  and  an  antimony  sensor  catheter  (VersaFlex®
isposable  pH  catheter,  Internal  Reference,  single  sensor,
lpine  Biomed,  Corp,  17800  Newhope  St,  Suite  B,  Fontaine
alley,  CA,  USA)  were  used.  The  catheter  was  placed  in  the
tomach  via  the  nose  and  the  sensor  was  positioned  5  cm
bove  the  LES  as  determined  by  manometry.  The  electrode
atheter  was  connected  to  the  portable  unit  and  recording
as  started.  The  patients  were  told  to  use  the  Digitrapper
vent  button  to  record  the  start  and  duration  of  each  painful
pisode,  mealtimes,  and  whether  they  were  in  supine
osition.  For  the  data  analysis,  the  Digitrapper  was  trans-
erred  to  a  personal  computer  and  processed  using  Polygram
etTM  Version:  4.01.525.45  software  (Copyright© 2001--2003
edtronic  A/S).  Gastroesophageal  reﬂux  was  determined  to
e  present  when  the  total  percentage  time  with  pH  <  4  in
4  h  was  >  4.2%  and/or  the  Johnson-DeMeester  composite
124  O.  Ortiz-Garrido  et  al.
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tigure  1  Tests  for  diagnosing  patients  with  non-cardiac  chest
CP: Functional  chest  pain;  GERD:  Gastroesophageal  reﬂux  dise
core  was  >  14.72.15 The  temporal  relation  between  CP  and
cid  reﬂux  episodes  was  considered  positive  with  a  symptom
ndex  >  50%.22 A  positive  correlation  with  symptom  associ-
tion  probability  was  considered  when  the  symptom  index
as  >  95%.23,24 The  relation  interval  with  the  CP  event  was
onsidered  for  2  min  before  and  after  the  symptom.
F-36  Quality  of  Life  Questionnaire
he  SF-36  Quality  of  Life  Questionnaire  consists  of  36  ques-
ions  that  cover  8  health  items:  1)  physical  functioning,  2)
ole  limitations  due  to  physical  health  problems,  3)  bodily
ain,  4)  general  health,  5)  vitality,  6)  social  functioning,  7)
ole  limitations  due  to  emotional  problems,  and  8)  mental
ealth.  These  are  grouped  into  the  2  general  subscales  of
ental  health  summary  and  physical  health  summary.  Low
cores  reﬂect  a  poor  perception  of  health,  loss  of  function-
ng,  and  the  presence  of  pain,  whereas  high  scores  reﬂect
 good  perception  of  health,  no  functional  deﬁcit,  and  no
ain.25
tatistical  analysis
esults  were  expressed  as  frequencies,  medians  (intervals),
nd  means  (±  SD).  Dichotomous  variables  were  compared
y  chi-square  or  Fisher’s  exact  tests.  Quality  of  life  scores
ere  compared  by  non-parametric  tests  (Kruskal-Wallis  and
ann  Whitney  U  tests).  Spearman’s  correlation  coefﬁcient
as  used  to  assess  the  correlation  between  quantitative
ariables.  A  value  of  p  <  0.05  was  considered  signiﬁcant.  The
nalysis  was  performed  by  means  of  the  SPSS  for  Windows
tatistical  package  (version  17.0;  SPSS,  Chicago,  IL,  USA).
esults
orty-eight  patients  with  NCCP  of  presumed  esophageal  ori-
in  were  evaluated  and  33  of  them,  20  women  and  13  men
ith  a  mean  age  of  46.1  (±11.6)  years,  were  included  in  the
tudy.  Fifteen  patients  were  excluded;  7  that  were  under
PI  treatment  and  8  that  did  not  agree  to  take  part  in  the
tudy.
f
i
w
n.
The  causes  of  NCCP  were  GERD  in  48%  (n=16)  of  the  sub-
ects,  classic  achalasia  in  34%  (n=11),  and  FCP  in  18%  (n=6).
requency  of  CP  events  and  their  duration  are  shown  in
able  1.
The  associated  symptoms  most  commonly  referred  in
ach  of  the  3  groups  were  regurgitation,  dysphagia,
nd  heartburn.  Heartburn  was  the  prevailing  symptom  in
atients  with  GERD  and  FCP,  whereas  dysphagia  and  regur-
itation  were  the  main  symptoms  in  patients  with  achalasia.
eight  loss  was  found  in  30.3%  of  the  patients,  clearly
redominating  in  the  group  with  achalasia,  where  it  was
eported  in  72%  of  the  cases  with  a  mean  of  9  kg  (±  2.4)
Table  2).
In the  group  of  subjects  with  GERD,  endoscopy  revealed
arious  degrees  of  esophagitis  in  4  of  the  16  patients  (A
 2;  B  =  1;  and  D  =  1),  one  patient  had  intestinal  meta-
lasia  conﬁrmed  by  histopathology,  and  11  patients  were
iagnosed  with  NERD.  Twenty-ﬁve  percent  of  the  patients
ad  failed  peristalsis  and  12%  mild  distal  esophageal  hypo-
otility,  whereas  peristalsis  was  normal  in  63%  of  the  cases.
uring  24-h  pH  monitoring,  19%  of  the  patients  reported  CP.
anometric  and  pH-metry  ﬁndings  are  shown  in  Table  3.
uality  of  Life
atients  with  NCCP  of  presumed  esophageal  origin  showed
eterioration  in  quality  of  life,  affecting  all  items  in  the
F-36  questionnaire,  compared  with  the  control  group  of
ubjects  with  no  esophageal  symptoms  (p  =  0.01).  The  most
ffected  items  were  perception  of  general  health  (GH)  and
imitations  due  to  emotional  problems.  The  subscale  with
he  greatest  change  was  mental  health  summary,  as  shown
n  Table  4.
Regarding  assessment  of  quality  of  life  in  relation  to  NCCP
tiology,  we  observed  differences  in  role  physical,  bodily
ain,  and  social  functioning,  although  they  were  not  sta-
istically  signiﬁcant  (ﬁg.  2).  When  evaluating  subscales,  we
ound  that  patients  with  GERD  and  FCP  were  mostly  affected
n  the  physical  health  summary  subscale  than  in  the  group
ith  achalasia,  although,  again,  there  was  no  statistical  sig-
iﬁcance  (p  =  0.08).
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Table  1  Basal  traits  of  the  study  group.
GERD
n  =  16  (%)
Achalasia
n  =  11(%)
FCP
n  =  6  (%)
p
Sex  Female/male  9/7  6/5  5/1  ns
Age, mean  (±  SD)  47.7  (2.7)  40.9  (3.5)  45.7  (9.6)  ns
Length of  CP  in  months,
median  (interval)
30  (2-180)  24  (6-240)  18  (6-60)  ns
Frequency of  CP,  n  (%)
> 3  events/day  4  (25)  4  (36)  2(33)  ns
> 3  events/week 4  (25) 1(9)  1  (17)  ns
≤ 3  events/week 8  (50) 6  (55) 3  (50) ns
CP: chest pain; GERD: Gastroesophageal reﬂux disease; FCP: Functional chest pain; ns: not signiﬁcant; SD: Standard deviation.
*T test to evaluate differences among means; ** Z or F test to evaluate difference among frequencies; ***Test of medians to evaluate
their differences.
Table  2  Clinical  data  of  the  study  population.
Symptoms  GERD
n  =  16(%)
Achalasia
n  =  11(%)
FCP
n  =  6(%)  p
Regurgitation  12  (75)  11  (100)*  4  (67)*  0.05
Dysphagia 9  (56)*  11  (100)*  4  (67)  0.03
Heartburn 13  (81)*  4  (36)*  5  (83)*  0.05
Nightly coughing  attacks  3  (19)  4  (36)  5  (83)  ns
Weight loss  2  (12)*  8  (72)*  0  0.05
Odynophagia  3  (19)  0  2  (33)  ns
Dysphonia 1  (6)  0  1  (17)  ns
e; ns
th sta
w
o
dFCP: Functional chest pain; GERD: Gastroesophageal reﬂux diseas
Z or F test to evaluate difference among frequencies; *: group wi
We  found  no  correlation  between  quality  of  life  and  the
frequency  and  duration  of  CP  events.Discussion
The  ﬁndings  in  our  study  showed  that  treatment-naïve
patients  with  NCCP  of  presumed  esophageal  origin  presented
b
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Table  3  Findings  of  esophageal  manometry  and  24-hour  esophag
GERD.
GERD
Manometry
LES  with  normal  pressure,  n  (%) 9  (5
Hypotensive  LES,  n  (%)  7  (4
Normal EP,  n  (%)  10  (6
Non-speciﬁc  motility  abnormalities,  n  (%)  2  (1
Ineffective  peristalsis,  n  (%)  4  (2
24-hour esophageal  pH-metry
DeMeester  composite  score  mean  (±  SD)  24.3
%  pH  time  <  4,  mean  (±  SD)  6.4
EP: Esophageal peristalsis; FCP: Functional chest pain; GERD: Gastroes
non-cardiac chest pain; ns: not signiﬁcant; SD: standard deviation.
* Z or F test to evaluate difference among rates.
** Non-paired t test to evaluate differences between means.: not signiﬁcant.
tistically signiﬁcant results.
ith  deterioration  in  quality  of  life,  regardless  of  CP  eti-
logy  (GERD,  achalasia,  and  FCP),  and  there  were  clinical
ifferences  that  may  suggest  the  cause  of  CP.
NCCP  is  a  complex  disorder  and  consequently  it  has
een  deﬁned  in  a number  of  ways.  A  recent  revision
rovides  2  commonly  used  deﬁnitions;26 the  ﬁrst  is  ‘‘CP
hat  is  not  angina  and  is  not  due  to  ischemic  coronary
isease’’,  while  the  second  states  ‘‘recurring  substernal  CP
eal  pH-metry  in  patients  with  functional  NCCP  secondary  to
n  =  16  FCP  n  =  6  p
6) 6  (100)  ns
4)  0  ns
3)  6  (100)  ns
2)  0  ns
5)  0  ns
 (±  8.3)  8.9  (±  2.8)  <  0.01**
 (±  3.2)  1.9  (±  0.6)  <  0.01**
ophageal reﬂux disease; LES: Lower esophageal sphincter; NCCP:
126  O.  Ortiz-Garrido  et  al.
Table  4  Results  of  the  SF-36  Health  Survey  in  patients  with  NCCP  (n  =  33)  and  the  control  group  (n  =  51).
SF-36  NCCPn  =  33  Healthy  subjectsn  =  51  p*
PF,  mean  (±  SD)  77.8  (20.4)  91  (18)  0.003
RP, mean  (±  SD)  63.3  (43.2)  84.7  (25.4)  0.01
BP, mean  (±  SD)  59.9  (24.6)  83.5  (15.6)  0.001
GH, mean  (±  SD) 50.4  (19.7)  67.9  (15.5)  0.001
VT, mean  (±  SD) 55.6  (21.4) 73  (12) 0.001
SF, mean  (±  SD) 72.3  (25.4) 86.3  (16) 0.002
RE, mean  (±  SD) 42.9  (31.4) 65.4  (26.6) 0.001
MH, mean  (±  SD)  61.6  (21.4)  75  (15)  0.002
MCS, mean  (±  SD)  42.6  (11.5)  53.6  (4.6)  0.001
PCS, mean  (±  SD)  45  (8.6)  58.3  (7.3)  0.05
BP: Bodily pain; GH: General health; MCS: Mental component summary; MH: Mental health; NCCP: Non-cardiac chest pain; PCS: Physical
component summary; PF: Physical functioning; RE: Role limitations due to emotional problems; RP: Role limitations due to physical
health problems; SF: Social functioning; VT: Vitality.
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r  discomfort  that  must  be  diagnosed  only  after  exclusion  of
on-esophageal  causes  such  as  heart,  musculoskeletal,  and
leuritic  diseases  and  other  disorders’’.  These  deﬁnitions
re  clearly  different,  and  there  is  still  no  deﬁnition  that
eems  to  adequately  classify  NCCP.  Fass  and  Achem  recently
eﬁned  NCCP  as  recurring  CP  episodes  that  cannot  be  dis-
inguished  from  ischemic  heart  pain  after  having  reasonably
uled  out  a  cardiac  cause.27 In  our  study  we  deﬁned  NCCP
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he mean  score  for  each  of  the  8  items  and  2  subscales  of  the  SF-3
ERD, and  FCP  are  shown.  High  values  reﬂect  a  perception  of  good  
y the  Kruskal-Wallis  test.  BP:  Bodily  pain;  FCP:  Functional  chest  pai
CS: Mental  component  summary;  MH:  Mental  health;  NCCP:  Non
hysical functioning;  RE:  Role  limitations  due  to  emotional  problem
ocial functioning;  VT:  Vitality.roups.
s  recurrent,  non-burning  episodes  of  retrosternal  chest
ain  that  is  unrelated  to  heart  disease.
Worldwide  epidemiology  of  NCCP  is  relatively  limited.
t  was  recently  reported  that  CP  is  the  second  most  com-
on  event  that  is  assessed  at  emergency  services;  however,
nly  25%  of  the  subjects  experiencing  CP  seek  hospital
are.  Annual  average  prevalence,  as  evaluated  in  6  dif-
erent  populations,  was  25%.  NCCP  is  found  in  similar
SF RE MH MCS  PCS
 FCPGERD
.
6  questionnaire  in  patients  with  NCCP  secondary  to  achalasia,
health.  The  difference  in  means  between  groups  was  assessed
n;  GERD:  Gastroesophageal  reﬂux  disease;  GH:  General  health;
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proportions  in  both  sexes,  although  women  tend  to  seek
medical  care  more  often.27 Among  the  Mexican  popula-
tion,  the  prevalence  and  distribution  by  sex  are  unknown.
In  our  study  we  found  a  predominance  of  women  of
up  to  61%,  and  when  analyzed  by  subgroup,  we  found
they  clearly  predominated  (83%)  in  the  FCP  group.  It  has
been  previously  described  that  females  with  functional
digestive  disorders  seek  medical  care  more  frequently,28
which  may  explain  the  high  prevalence  of  women  with
FCP.
Identifying  the  cause  of  NCCP  is  still  a  problem  in  clinical
practice,  and  because  little  is  known  regarding  its  patho-
physiology,  its  mechanisms  are  numerous  and  overlapping.
The  main  causes  of  NCCP  are  esophageal  and  psychiatric
disorders,  as  well  as  musculoskeletal  alterations.29 The
most  frequent  cause  of  NCCP  of  presumed  esophageal  ori-
gin  is  GERD,  present  in  approximately  60%  of  the  cases.30
In  contrast,  only  a  minority  of  patients  with  CP  show  a
motor  esophageal  disorder.31 Therefore,  the  empirical  use  of
therapeutic  testing  with  acid  secretion  inhibitors  has  been
suggested  as  an  initial  diagnostic  and  therapeutic  maneu-
ver  in  patients  with  NCCP.27 In  our  population,  48%  of  the
subjects  had  GERD  as  determined  by  endoscopy  and/or  24-h
esophageal  pH-metry.  The  typical  symptoms  of  reﬂux,  heart-
burn,  and  regurgitation  were  found  in  more  than  75%  of  the
patients,  with  a  clear  predominance  of  heartburn  in  81%.
The  incidence  of  abnormalities  in  the  esophageal  mucosa
consistent  with  GERD  was  25%  and  there  was  only  one  case
of  intestinal  metaplasia.  In  the  various  populations  studied,
esophagitis  associated  with  NCCP  was  reported  in  10-70%  of
the  cases.32 During  ambulatory  24-h  pH  monitoring,  only  19%
of  the  patients  reported  CP,  lower  than  the  21-44%  previously
described.33
The  relation  between  NCCP  and  esophageal  dysmotil-
ity  is  still  a  highly  controversial  topic.  Several  studies  have
shown  that  approximately  30%  of  patients  with  NCCP  show
alterations  in  esophageal  manometry.  However,  informa-
tion  regarding  alterations  in  esophageal  motility  in  patients
with  NCCP  that  is  not  associated  with  GERD  is  still  scarce.
Dekel  et  al.  identiﬁed  hypotension  of  the  LES,  found  in
61%,  as  the  most  frequent  motor  disorder  in  this  popu-
lation,  followed  by  hypertension  of  the  LES,  non-speciﬁc
motor  disorders,  and  nutcracker  esophagus.34 In  contrast,
Katz  et  al.  reported  that  the  most  frequent  motor  dis-
order  was  nutcracker  esophagus,  followed  by  non-speciﬁc
motor  disorders,  diffuse  esophageal  spasm,  hypotension  of
the  LES,  and  achalasia.35 In  our  analysis,  the  only  esophageal
motor  disorder  evaluated  was  classic  achalasia,  due  to  the
low  frequency  of  the  other  primary  motor  disorders  of  the
esophagus  in  the  study  population.  In  patients  with  classic
achalasia,  we  noticed  that  the  symptoms  most  frequently
observed  were  regurgitation  and  dysphagia  in  100%  of  the
subjects,  along  with  signiﬁcant  weight  loss  in  up  to  72%;
both  of  these  ﬁndings  were  signiﬁcantly  different  between
the  study  populations.
In the  most  recent  revision  of  the  Rome  Criteria  for  Func-
tional  Gastrointestinal  Disorders,  the  deﬁnition  of  FCP  of
presumed  esophageal  origin  was  modiﬁed.9 In  our  study,
patients  with  NCCP  unrelated  to  GERD  or  primary  esophageal
motor  disorders  were  classiﬁed  as  FCP  in  agreement  with
the  Rome  III  criteria,17,36 which  presented  several  symptoms
associated  with  CP.
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Although  the  most  common  cause  of  NCCP  is  reported
o  be  esophageal,  ruling  out  psychiatric  disorders  during
he  initial  evaluation  is  recommended.  More  than  one  study
eports  that  patients  with  NCCP  secondary  to  GERD  and
CP  have  disorders  associated  with  anxiety  and  depression,
hich  generally  overlap.  In  a  previous  study  we  found
hat  51%  of  patients  with  NCCP  had  a  psychopathological
isorder.  Among  these,  depression  was  the  most  prevalent
ith  33%;  more  than  50%  of  these  cases  required  manage-
ent  and  follow  up  by  a  psychiatrist.  Anxiety  disorders,
ncluding  panic  attacks  and  general  anxiety,  were  present
n  6.5%  of  the  cases.37
It  is  accepted  that  NCCP  has  an  impact  on  the  quality
f  life  of  the  subjects  suffering  from  it;  however,  studies  to
ssess  quality  of  life  in  this  group  of  patients  are  still  limited.
he  scant  information  currently  available  indicates  that  the
ffect  is  universal  and  does  not  differ  between  those  that
rrive  at  emergency  services  and  those  that  live  with  NCCP
n  the  community.  It  has  been  reported  that  the  severity  of
P  is  important  and  that  quality  of  life  deteriorates  as  its
everity  increases.3
Wong  et  al.  compared  quality  of  life  between  healthy
ubjects  and  those  with  NCCP  and  found  that  patients  with
CCP  were  affected  in  all  items  of  the  SF-36,  compared  with
ealthy  subjects,  especially  in  regard  to  physical  function-
ng,  role  limitations  due  to  physical  health  problems,  and
erception  of  GH.38 In  our  study  we  found  a  negative  impact
n  quality  of  life  in  all  areas  of  the  SF-36  when  compared
ith  healthy  subjects  (those  without  esophageal  symptoms)
nd  the  most  affected  areas  were  perception  of  GH  and  lim-
tations  due  to  emotional  problems.  Nevertheless  we  found
o  correlation  between  quality  of  life  and  the  intensity  of
ain,  as  has  been  previously  described.3
Quality  of  life  has  also  been  assessed  in  patients  with
CCP  and  CP  of  cardiac  origin  and  differences  have  been
eported.  However,  we  have  not  found  reports  in  the  lit-
rature  where  quality  of  life  is  compared  according  to
CCP  etiology.  We  evaluated  and  compared  quality  of  life
n  relation  to  etiology  in  patients  with  NCCP  of  presumed
sophageal  origin  and  found  that  those  with  GERD,  acha-
asia,  and  CP  had  signiﬁcant  deterioration  in  quality  of
ife,  and  that  the  various  items  of  the  SF-36  were  similarly
ffected.  This  suggests  that  there  may  be  no  difference
n  the  perception  of  the  disease  at  either  a physical  and
motional  level;  however,  our  results  must  be  conﬁrmed  by
tudies  on  a  larger  group  of  subjects.
The  limitations  of  the  study  include  the  following:  1)
he  number  of  subjects  evaluated  per  group  was  small,
hus  limiting  our  conclusions,  2)  a  general  quality  of  life
urvey  was  used  and  it  was  not  possible  to  administer
 speciﬁc  questionnaire  per  NCCP  etiology;  3)  we  only
ncluded  patients  with  classic  achalasia,  excluding  other
rimary  motor  disorders  of  the  esophagus,  such  as  vigor-
us  achalasia,  in  which  CP  has  clinical  and  pathophysiologic
haracteristics  that  differ  from  the  other  primary  motor  dis-
rders  of  the  esophagus;  and  4)  no  proton  pump  inhibitor
herapeutic  trial  was  performed.
The  ﬁndings  of  the  study  suggest  that  patients  with  NCCP
n  our  population  have  a poor  quality  of  life  regardless  of
he  etiology,  frequency,  and  symptoms  that  are  associated
ith  CP;  the  most  affected  items  were  perception  of  general
ealth  and  limitations  due  to  emotional  problems.  Prompt
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